Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in La Palma, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
What is Market Cap of Liminatus Pharma Inc. - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Liminatus Pharma Inc. - Ordinary Shares - Class A market cap is $38.16M.
What is the 52-week high for Liminatus Pharma Inc. - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Liminatus Pharma Inc. - Ordinary Shares - Class A 52 week high is $33.66 as of October 15, 2025.
What is the 52-week low for Liminatus Pharma Inc. - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Liminatus Pharma Inc. - Ordinary Shares - Class A 52 week low is $1.12 as of October 15, 2025.
What is Liminatus Pharma Inc. - Ordinary Shares - Class A stock price today?
Liminatus Pharma Inc. - Ordinary Shares - Class A stock price today is $1.35.
What was Liminatus Pharma Inc. - Ordinary Shares - Class A stock price yesterday?
Liminatus Pharma Inc. - Ordinary Shares - Class A stock price yesterday was $1.41.
What is the PE ratio of Liminatus Pharma Inc. - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Liminatus Pharma Inc. - Ordinary Shares - Class A’s P/E ratio is -6.80.
What is the Price-to-Book ratio of Liminatus Pharma Inc. - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Liminatus Pharma Inc. - Ordinary Shares - Class A P/B ratio is -4.1647.
What is the 50-day moving average of Liminatus Pharma Inc. - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Liminatus Pharma Inc. - Ordinary Shares - Class A 50-day moving average is $2.67.
How many employess does Liminatus Pharma Inc. - Ordinary Shares - Class A has?
Liminatus Pharma Inc. - Ordinary Shares - Class A has 3 employees.
